It is generally recognized that IL-1β is a constituent of the combination of pro-inflammatory cytokines responsible for the inflammation seen in IBD patients and that increases in IL-1β levels are related to higher disease severity (44). The gene discussed is IL1B; the disease is inflammatory bowel disease.